Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.
Clinical trial NCT05142553 · COMPLETED
Trial details
- NCT number
- NCT05142553
- Sponsor
- Hipra Scientific, S.L.U
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-16
- Primary completion
- 2023-05-29
- Enrollment
- 887
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.